多款“抗癌药”将亮相第二届进博会 - 2019年09月12日

Leading pharmaceutical companies will be taking part in the second China International Import Expo in an effort to to introduce more anti-cancer drugs to the Chinese market.
Several enterprises, including Pfizer Biopharmaceuticals Group, Roche Pharmaceuticals and Merck Sharp & Dohme (MSD), introduced the drugs they will exhibit at November’s expo at a support session for its health care exhibition area.
Wu Kun, country lead of Pfizer China Biopharma, said the company will bring several medicines including Ibrance, a treatment for advanced-stage breast cancer.